Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study

被引：0
|
作者：
Peng Yang
Xiao Zhou
Xuefeng Yang
Yuefeng Wang
Tao Sun
Shiying Feng
Xianyou Ma
机构：
[1] Daqing Oilfield General Hospital,Department of Cardiothoracic Surgery
[2] Daqing Oilfield General Hospital,Department of Oncology
来源：
World Journal of Surgical Oncology | / 19卷
关键词：
Camrelizumab; Chemotherapy; Neoadjuvant therapy; Esophageal squamous cell carcinoma; Efficacy and safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Yang, Peng
    Zhou, Xiao
    Yang, Xuefeng
    Wang, Yuefeng
    Sun, Tao
    Feng, Shiying
    Ma, Xianyou
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [2] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    FRONTIERS IN SURGERY, 2022, 9
  • [3] Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
    Zhou, Rui-Qin
    Luo, Jun
    Li, Lin-Jun
    Du, Ming
    Wu, Qing-Chen
    BMC SURGERY, 2023, 23 (01)
  • [4] Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
    Rui-Qin Zhou
    Jun Luo
    Lin-Jun Li
    Ming Du
    Qing-Chen Wu
    BMC Surgery, 23
  • [5] ORIGINAL RESE ARCH The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study
    Yin, Guo-Qiang
    Li, Zu-Lei
    Li, Dong
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2133 - 2141
  • [6] The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma
    Xu, Weili
    Jiang, Youhua
    Wang, Changchun
    Wu, Jie
    Li, Jianqiang
    Hu, Yuqian
    Lu, Weishan
    Shen, Dijian
    Wang, Yinjie
    Chen, Qixun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [7] Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study
    Sheng, Yinliang
    Meng, Xiangrui
    Zhang, Chunyang
    Shan, Zhengzheng
    Li, Feng
    Wu, Bin
    Xu, Mengli
    Li, Aijia
    Guan, Lulu
    Chen, Lidong
    Sun, Shuzhen
    Ma, Yihui
    Lu, Taiying
    Zhao, Song
    Fan, Qingxia
    Qi, Yu
    Wang, Feng
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5337 - 5347
  • [8] Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1113 - S1113
  • [9] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer
    Zhang, Baihua
    Zhao, Hongbo
    Wu, Xun
    Gong, Lianghui
    Yang, Desong
    Li, Xu
    Chen, Xiaoyan
    Li, Jigang
    Wang, Wenxiang
    Wu, Jie
    Xiao, Qin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345